Nifty
:
24273.80
Sensex
:
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)
Nifty
Sensex
:
:
24273.80
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :
N/A

BSE: 506943 | NSE: JBCHEPHARM

NSE BSE
1716.45
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1739.50
  •  1760.90
  •  1707.00
  •  1713.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  142923
  •  2459.42
  •  2030.00
  •  1385.75

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 23,936.13
  • 37.40
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 23,920.31
  • 0.80%
  • 7.09

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 47.84%
  • 0.50%
  • 13.28%
  • FII
  • DII
  • Others
  • 18.3%
  • 18.03%
  • 2.05%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.78
  • 14.44
  • 12.85

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.36
  • 18.77
  • 10.46

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.59
  • 15.23
  • 12.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.67
  • 37.67
  • 44.81

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.21
  • 7.04
  • 7.95

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.03
  • 22.89
  • 26.72

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
35.66
45.34
54.9
63.64
P/E Ratio
49.14
38.65
31.92
27.54
Revenue
3449
4038
4554
5114
EBITDA
892
1087
1261
1453
Net Income
553
706
858
996
ROA
14.6
16.5
18
18.3
P/B Ratio
9.3
7.85
6.55
5.47
ROE
20.45
22
22.36
21.92
FCFF
633.61
644.65
743.4
551.92
FCFF Yield
2.34
2.38
2.74
2.04

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
963.49
844.51
14.09%
1,000.62
881.74
13.48%
1,004.40
896.20
12.07%
861.73
762.32
13.04%
Expenses
708.98
621.39
14.10%
730.10
638.20
14.40%
724.03
664.09
9.03%
663.61
598.68
10.85%
EBITDA
254.51
223.12
14.07%
270.52
243.54
11.08%
280.37
232.11
20.79%
198.12
163.64
21.07%
EBIDTM
26.42%
26.42%
27.04%
27.62%
27.91%
25.90%
22.99%
21.47%
Other Income
8.00
7.35
8.84%
9.95
7.66
29.90%
5.89
5.63
4.62%
16.63
4.58
263.10%
Interest
2.58
12.49
-79.34%
2.06
10.37
-80.14%
5.64
12.06
-53.23%
9.41
13.96
-32.59%
Depreciation
41.94
34.03
23.24%
41.88
32.17
30.18%
40.78
31.38
29.96%
40.74
31.80
28.11%
PBT
217.99
183.95
18.51%
236.53
208.66
13.36%
239.84
194.30
23.44%
164.60
122.46
34.41%
Tax
55.50
50.38
10.16%
61.96
58.07
6.70%
63.01
51.98
21.22%
38.44
34.83
10.36%
PAT
162.49
133.57
21.65%
174.57
150.59
15.92%
176.83
142.32
24.25%
126.16
87.63
43.97%
PATM
16.86%
15.82%
17.45%
17.08%
17.61%
15.88%
14.64%
11.50%
EPS
10.45
8.62
21.23%
11.24
9.72
15.64%
11.39
9.19
23.94%
8.13
5.66
43.64%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
3,830.24
3,484.18
3,149.28
2,424.24
2,042.52
1,774.73
1,643.20
1,413.77
1,368.32
1,231.58
1,144.21
Net Sales Growth
13.16%
10.63%
29.91%
18.69%
15.09%
8.00%
16.23%
3.32%
11.10%
7.64%
 
Cost Of Goods Sold
1,295.19
1,182.05
1,168.20
842.93
701.50
630.80
596.46
542.41
552.00
491.41
341.40
Gross Profit
2,535.05
2,302.13
1,981.08
1,581.31
1,341.02
1,143.93
1,046.74
871.35
816.32
740.17
802.81
GP Margin
66.19%
66.07%
62.91%
65.23%
65.66%
64.46%
63.70%
61.63%
59.66%
60.10%
70.16%
Total Expenditure
2,826.72
2,591.70
2,453.53
1,881.63
1,486.35
1,397.15
1,337.36
1,214.64
1,135.93
1,025.55
964.09
Power & Fuel Cost
-
88.08
91.54
71.47
62.60
61.54
63.29
58.28
54.89
55.28
53.02
% Of Sales
-
2.53%
2.91%
2.95%
3.06%
3.47%
3.85%
4.12%
4.01%
4.49%
4.63%
Employee Cost
-
601.41
543.45
439.24
340.60
322.92
288.18
251.10
217.34
175.31
159.56
% Of Sales
-
17.26%
17.26%
18.12%
16.68%
18.20%
17.54%
17.76%
15.88%
14.23%
13.94%
Manufacturing Exp.
-
234.82
210.91
194.00
148.68
140.70
150.49
139.83
131.45
119.35
223.53
% Of Sales
-
6.74%
6.70%
8.00%
7.28%
7.93%
9.16%
9.89%
9.61%
9.69%
19.54%
General & Admin Exp.
-
119.69
110.09
100.46
56.35
48.14
52.97
53.96
42.26
34.82
32.46
% Of Sales
-
3.44%
3.50%
4.14%
2.76%
2.71%
3.22%
3.82%
3.09%
2.83%
2.84%
Selling & Distn. Exp.
-
268.40
233.96
161.80
113.22
116.95
113.59
87.44
78.27
72.72
75.13
% Of Sales
-
7.70%
7.43%
6.67%
5.54%
6.59%
6.91%
6.18%
5.72%
5.90%
6.57%
Miscellaneous Exp.
-
97.24
95.38
71.72
63.38
76.11
72.38
81.61
59.72
76.65
75.13
% Of Sales
-
2.79%
3.03%
2.96%
3.10%
4.29%
4.40%
5.77%
4.36%
6.22%
6.91%
EBITDA
1,003.52
892.48
695.75
542.61
556.17
377.58
305.84
199.13
232.39
206.03
180.12
EBITDA Margin
26.20%
25.62%
22.09%
22.38%
27.23%
21.28%
18.61%
14.09%
16.98%
16.73%
15.74%
Other Income
40.47
41.67
9.94
40.07
116.62
50.90
41.44
55.29
50.16
56.65
10.89
Interest
19.69
44.33
36.05
5.12
7.24
3.26
4.65
3.49
5.37
10.65
6.82
Depreciation
165.34
138.32
114.41
72.66
68.67
66.32
55.64
56.97
47.22
41.22
38.64
PBT
858.96
751.51
555.23
504.90
596.89
358.89
286.99
193.95
229.94
210.82
145.55
Tax
218.91
198.88
145.23
118.86
148.36
76.50
93.02
55.23
45.55
49.58
45.14
Tax Rate
25.49%
26.46%
26.16%
23.54%
24.86%
21.93%
32.41%
28.48%
19.81%
23.52%
31.01%
PAT
640.05
552.63
409.84
385.36
447.96
272.04
193.47
138.34
184.06
161.14
100.41
PAT before Minority Interest
640.05
552.63
410.01
386.04
448.52
272.39
193.97
138.72
184.40
161.24
100.41
Minority Interest
0.00
0.00
-0.17
-0.68
-0.56
-0.35
-0.50
-0.38
-0.34
-0.10
0.00
PAT Margin
16.71%
15.86%
13.01%
15.90%
21.93%
15.33%
11.77%
9.79%
13.45%
13.08%
8.78%
PAT Growth
24.50%
34.84%
6.35%
-13.97%
64.67%
40.61%
39.85%
-24.84%
14.22%
60.48%
 
EPS
41.11
35.49
26.32
24.75
28.77
17.47
12.43
8.89
11.82
10.35
6.45

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
2,923.33
2,480.35
2,134.12
1,809.72
1,435.49
1,480.12
1,441.56
1,363.67
1,183.84
994.87
Share Capital
15.52
15.48
15.46
15.46
15.46
16.05
16.71
16.96
16.96
16.96
Total Reserves
2,767.97
2,343.26
2,056.01
1,794.27
1,420.03
1,464.08
1,424.84
1,346.70
1,166.87
977.91
Non-Current Liabilities
465.96
992.03
475.34
72.47
62.72
64.84
45.66
26.98
31.02
32.62
Secured Loans
23.64
383.22
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.40
Long Term Provisions
287.66
494.68
410.43
12.57
7.39
5.73
9.67
12.56
10.43
12.03
Current Liabilities
1,287.76
625.70
455.16
686.57
516.19
781.54
736.50
693.46
797.22
459.75
Trade Payables
356.31
238.65
224.48
186.92
167.97
117.37
110.39
98.98
90.85
77.51
Other Current Liabilities
435.75
240.33
81.31
89.82
102.67
93.10
119.75
122.15
138.73
103.74
Short Term Borrowings
15.34
28.02
26.32
32.64
29.49
25.80
29.29
48.86
193.02
126.88
Short Term Provisions
480.35
118.71
123.06
377.17
216.06
545.27
477.06
423.47
374.61
151.62
Total Liabilities
4,677.05
4,098.08
3,069.11
2,572.47
2,016.90
2,329.30
2,226.49
2,086.29
2,013.75
1,487.24
Net Block
2,004.40
1,901.01
1,276.99
633.65
651.26
620.93
639.50
679.44
440.22
328.56
Gross Block
2,835.23
2,607.77
1,876.20
1,182.55
1,177.43
1,084.83
1,053.76
1,038.55
753.75
601.67
Accumulated Depreciation
830.83
706.76
599.21
548.90
526.17
463.89
414.25
359.10
313.53
273.11
Non Current Assets
2,404.17
2,498.80
1,744.51
678.57
740.83
740.80
717.89
879.15
831.58
586.31
Capital Work in Progress
76.40
55.15
18.68
25.57
16.17
15.09
17.40
3.76
134.89
55.17
Non Current Investment
23.71
13.78
12.72
12.91
69.45
95.88
49.96
185.84
231.42
184.83
Long Term Loans & Adv.
293.64
514.35
435.07
5.62
3.59
8.31
10.15
9.43
22.63
17.74
Other Non Current Assets
6.03
14.51
1.04
0.82
0.36
0.59
0.88
0.67
2.43
0.00
Current Assets
2,272.87
1,599.29
1,324.61
1,893.89
1,276.08
1,588.51
1,508.59
1,207.14
1,182.16
900.94
Current Investments
364.65
192.18
0.00
664.97
333.81
360.65
383.77
224.96
247.28
366.78
Inventories
502.51
430.48
409.96
347.45
274.67
243.76
213.73
200.17
187.98
150.27
Sundry Debtors
686.92
575.80
555.69
389.02
345.43
308.22
300.73
265.97
272.64
262.35
Cash & Bank
95.54
78.81
58.53
30.85
30.95
36.80
29.92
13.39
12.90
25.19
Other Current Assets
623.25
44.91
57.43
45.95
291.22
639.08
580.44
502.66
461.34
96.35
Short Term Loans & Adv.
590.16
277.09
243.00
415.66
272.33
605.85
567.50
488.30
458.83
95.97
Net Current Assets
985.12
973.58
869.45
1,207.33
759.88
806.97
772.10
513.68
384.94
441.19
Total Assets
4,677.04
4,098.09
3,069.12
2,572.46
2,016.91
2,329.31
2,226.48
2,086.29
2,013.74
1,487.25

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
800.61
625.61
170.13
314.78
275.75
194.33
122.92
201.13
140.41
126.66
PBT
751.51
555.23
504.90
596.89
348.89
286.99
193.95
229.94
212.23
145.55
Adjustment
187.22
195.78
102.27
-46.17
7.95
23.72
16.91
13.11
-1.40
38.51
Changes in Working Capital
-5.64
-29.92
-302.42
-94.21
9.70
-51.47
-47.07
5.92
-16.96
-19.52
Cash after chg. in Working capital
933.10
721.09
304.75
456.50
366.55
259.24
163.79
248.97
193.88
164.53
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-132.49
-95.48
-134.62
-141.72
-90.80
-64.91
-40.87
-47.84
-53.47
-37.87
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-403.83
-961.79
2.32
-230.68
23.93
-27.67
-20.68
-45.31
-27.62
-111.89
Net Fixed Assets
-247.88
-761.82
-681.80
-12.39
-94.42
-29.82
-29.56
-152.86
-187.76
-69.64
Net Investments
-192.30
-193.24
665.16
-274.62
53.26
-22.80
-22.92
67.89
-14.16
-61.38
Others
36.35
-6.73
18.96
56.33
65.09
24.95
31.80
39.66
174.30
19.13
Cash from Financing Activity
-385.49
356.54
-138.39
-87.42
-306.05
-155.74
-59.52
-183.84
-99.62
-1.39
Net Cash Inflow / Outflow
11.30
20.36
34.07
-3.31
-6.38
10.92
42.72
-28.02
13.17
13.38
Opening Cash & Equivalents
76.93
56.54
22.47
25.75
32.14
21.24
-21.47
6.54
-5.46
11.81
Closing Cash & Equivalent
88.22
76.93
56.54
22.47
25.75
32.14
21.24
-21.47
9.42
25.19

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
179.35
152.42
134.02
234.17
185.75
184.47
172.50
160.77
139.57
117.31
ROA
12.60%
11.44%
13.69%
19.55%
12.53%
8.52%
6.43%
8.99%
9.21%
7.08%
ROE
21.49%
18.51%
19.89%
27.64%
18.69%
13.28%
9.89%
14.48%
14.80%
9.86%
ROCE
25.23%
22.79%
25.48%
36.53%
23.71%
19.59%
13.70%
16.87%
17.72%
13.49%
Fixed Asset Turnover
1.32
1.46
1.63
1.73
1.57
1.54
1.35
1.53
1.82
2.03
Receivable days
63.93
63.16
69.29
65.62
67.22
67.63
73.15
71.84
79.28
78.41
Inventory Days
47.24
46.91
55.55
55.59
53.31
50.81
53.43
51.77
50.12
44.83
Payable days
91.86
72.35
89.07
92.33
38.74
32.21
33.66
32.86
32.45
27.82
Cash Conversion Cycle
19.31
37.72
35.77
28.88
81.79
86.23
92.93
90.75
96.95
95.43
Total Debt/Equity
0.13
0.23
0.01
0.02
0.02
0.02
0.02
0.04
0.16
0.13
Interest Cover
17.95
16.40
99.60
83.43
108.09
62.74
56.54
43.81
20.80
22.33

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • J.B. Chemicals & Pharmaceuticals secures USFDA’s approval for Bisoprolol Tablets
    21st Apr 2025, 14:21 PM

    Bisoprolol Tablets is indicated in the management of hypertension

    Read More
  • USFDA completes inspection of J.B. Chemicals’ formulations manufacturing facility in Gujarat
    10th Mar 2025, 10:58 AM

    The said audit has been successfully completed by the USFDA with ‘No Observations’ and thus NO Form 483 was issued

    Read More
  • JB Chem & Pharma - Quarterly Results
    4th Feb 2025, 18:55 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.